Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| FATE THERAPEUTICS INC | 55,000 | reported | 29 May 2025 | tx 24+510,388−64,488 |
| Omega Therapeutics, Inc. | 25,000 | reported | 20 Jun 2024 | tx 3+61,236 |
| aTYR PHARMA INC | 20,000 | reported | 08 May 2019 | tx 22+1,237,857−191,340 |
| Editas Medicine, Inc. | 11,538 | reported | 15 Jun 2017 | tx 2+107,691 |
| Monogram Biosciences, Inc. | 3,500 | reported | 16 Jan 2009 | tx 4+63,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2025 | GRANT_AWARD | FATE THERAPEUTICS INC | 55,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Omega Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | FATE THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | Omega Therapeutics, Inc. | 18,118 | 0.00 USD | deriv |
| 06 Jun 2023 | GRANT_AWARD | FATE THERAPEUTICS INC | 40,000 | 0.00 USD | deriv |
| 19 Jan 2023 | EXERCISE | FATE THERAPEUTICS INC | 28,461 | 1.37 USD | |
| 19 Jan 2023 | EXERCISE | FATE THERAPEUTICS INC | 28,461 | 0.00 USD | deriv |
| 13 Jan 2023 | PURCHASE | FATE THERAPEUTICS INC | 36,631 | 5.43 USD | |
| 11 Jan 2023 | PURCHASE | FATE THERAPEUTICS INC | 88,048 | 5.67 USD | first after silence |
| 09 Jun 2022 | GRANT_AWARD | FATE THERAPEUTICS INC | 8,650 | 0.00 USD | |
| 09 Jun 2022 | GRANT_AWARD | FATE THERAPEUTICS INC | 11,893 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Omega Therapeutics, Inc. | 18,118 | 0.00 USD | deriv |
| 03 Jun 2022 | SALE | FATE THERAPEUTICS INC | 1,364 | 22.79 USD | |
| 10 Mar 2022 | EXERCISE | FATE THERAPEUTICS INC | 31,562 | 1.63 USD | |
| 10 Mar 2022 | SALE | FATE THERAPEUTICS INC | 12,069 | 35.48 USD | |
| 10 Mar 2022 | SALE | FATE THERAPEUTICS INC | 19,493 | 34.73 USD | |
| 10 Mar 2022 | EXERCISE | FATE THERAPEUTICS INC | 31,562 | 0.00 USD | deriv |
| 02 Jun 2021 | GRANT_AWARD | FATE THERAPEUTICS INC | 2,681 | 0.00 USD | |
| 02 Jun 2021 | GRANT_AWARD | FATE THERAPEUTICS INC | 4,334 | 0.00 USD | deriv |
| 01 May 2020 | GRANT_AWARD | FATE THERAPEUTICS INC | 16,000 | — | deriv |
| 08 May 2019 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
| 03 May 2019 | GRANT_AWARD | FATE THERAPEUTICS INC | 16,000 | — | deriv |
| 21 Dec 2018 | PURCHASE | aTYR PHARMA INC | 195,000 | 0.42 USD | |
| 20 Dec 2018 | PURCHASE | aTYR PHARMA INC | 50,000 | 0.41 USD | first after silence |
| 15 May 2018 | GRANT_AWARD | aTYR PHARMA INC | 20,000 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 11 Jan 2023.